• OPEN AN ACCOUNT
Indian Indices
Sensex
74,529.08 -329.91
( -0.44%)
Global Indices
Nasdaq
51,895.24 -174.59
(-0.34%)
Dow Jones
7,786.35 0.65
(0.01%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,723.15 -15.86
(-0.15%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
74.2682595
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
40.78
408.59
EPS(TTM)
Face Value()
Div & Yield %
6.43
10
0
 

India Glycols consolidated net profit rises 35.71% in the March 2026 quarter
May 15,2026
Net profit of India Glycols rose 35.71% to Rs 86.88 crore in the quarter ended March 2026 as against Rs 64.02 crore during the previous quarter ended March 2025. Sales rose 13.11% to Rs 976.35 crore in the quarter ended March 2026 as against Rs 863.22 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.78% to Rs 292.76 crore in the year ended March 2026 as against Rs 230.92 crore during the previous year ended March 2025. Sales rose 11.76% to Rs 4211.41 crore in the year ended March 2026 as against Rs 3768.26 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales976.35863.22 13 4211.413768.26 12
OPM %17.0516.91 -15.4213.56 -
PBDT153.69114.38 34 533.42407.52 31
PBT112.4681.79 37 378.04292.32 29
NP86.8864.02 36 292.76230.92 27